{
    "clinical_study": {
        "@rank": "88847", 
        "arm_group": [
            {
                "arm_group_label": "Metronidazole", 
                "arm_group_type": "Active Comparator", 
                "description": "active drug: metronidazole 500mg three time per day for 10 days"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo three times per day for 10days"
            }
        ], 
        "brief_summary": {
            "textblock": "Recent study showed that SIBO is common among postgastrectomy patients and It appears to be\n      associated with postprandial intestinal symptoms and might aggravate late hypoglycemia. SIBO\n      could be a new therapeutic target for managing intestinal symptoms in postgastrectomy\n      patients.The purpose of this study is to determine whether antiboitic (metronidazole) is\n      effective in patients with postgasrectomy syndrome"
        }, 
        "brief_title": "Effects and Safety of Metronidazole in Patients With Gastrectomy", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Post Gastrectomy State", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 70\n\n          -  gastrectomy for early gastric cancer with complete resection\n\n          -  no reccurrence after follow up more than 6 months\n\n          -  identified small bowel bacterial overgrowth by hydrogen breath test\n\n          -  symptoms of postgastrectomy syndrome\n\n        Exclusion Criteria:\n\n          -  hypersensive to metronidazole\n\n          -  systemic chemotherapy history\n\n          -  other organic gastrointestinal disease (inflammatory bowel disease, carcinoid\n             syndrome, amyloidosis, intestinal obstruction)\n\n          -  other gastrointestinal operation history except appendectomy, cholecystectomy)\n\n          -  recent colonoscopic examination (within 30 days)\n\n          -  uncontrolled psychopathy\n\n          -  drug or alcohol abuser\n\n          -  pregnant or breast feeding woman\n\n          -  recent history of antibiotics treatment (within 90 days)\n\n          -  recent history of PPI or H2 blocker treatment (within 30 dyas)\n\n          -  recent history of probiotics treatment (within 30 dyas)\n\n          -  recent history of prokinetics or antispasmotic treatment (within 15 days)\n\n          -  severe systemic illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "170", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01658852", 
            "org_study_id": "Gastrectomy-MDZ-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metronidazole", 
                "intervention_name": "metronidazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Metronidazole"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 6, 2012", 
        "number_of_arms": "2", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Republic of Korea : Korea Food and Drug Administration (KFDA)"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Patient's Global Assessment of abdominal symptom", 
            "safety_issue": "Yes", 
            "time_frame": "4 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01658852"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Catholic University of Korea", 
            "investigator_full_name": "Myung-gui Choi", 
            "investigator_title": "prof.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The Catholic University of Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Catholic University of Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}